in this issue
Current role of allogeneic stem cell transplantation in breast cancer
Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysis
Interplay of distinct growth factors during epithelial–mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies
What happened in Italy? A brief summary of studies conducted in Italy to evaluate the impact of the smoking ban
Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer
Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer
Who is prone to high levels of distress after prophylactic mastectomy and/or salpingo-ovariectomy?
A dose escalation trial of adjuvant cyclophosphamide and epirubicin in combination with 5-fluorouracil using G-CSF support for premenopausal women with breast cancer involving four or more positive nodes
Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study
Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients
Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: A proposal for standardization of patient characteristic reporting and stratification
Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial
Patterns of disease progression and outcomes in a randomized trial testing ABVD alone for patients with limited-stage Hodgkin lymphoma†
FDG-PET in T-cell and NK-cell neoplasms
Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-α2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanoma
Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer
Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineered™ monoclonal antibody targeting human EpCAM, in patients with advanced solid tumors
Burden of cervical cancer in Europe: estimates for 2004
Incidence of childhood cancer of the head and neck in Germany
Up-to-date monitoring of childhood cancer long-term survival in Europe: tumours of the sympathetic nervous system, retinoblastoma, renal and bone tumours, and soft tissue sarcomas
Up-to-date monitoring of childhood cancer long-term survival in Europe: central nervous system tumours
Oxytocin: bringing magic into nipple aspiration
Neutrophilic dermatitis associated with bortezomib in a patient with multiple myeloma
Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome
Reversible cognitive disorders after sunitinib for advanced renal cell cancer in patients with preexisting arteriosclerotic leukoencephalopathy
Overdose with 6400 mg of imatinib: is it safe?
Profound graft-versus-tumor response in metastatic breast cancer with nonmyeloablative allografting